ARDT Ardent Health, Inc.

ARDT financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1756655 Exchange: NYSE SIC: 8062 (Services-General Medical & Surgical Hospitals, NEC) Latest filing: 10-Q filed Aug 10, 2026 Data checked: Oct 21, 2026
Showing 3 of 4 annual and 0 of 14 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Accelerated filer
Entity Type
Operating
Public Float
$324.30M (Jun 2025)
Industry (SIC)
8062 Services-General Medical & Surgical Hospitals, NEC
Incorporated
DE
Fiscal Year End
December (1231)
Phone
6152963000
EIN
611764793
Headquarters
BRENTWOOD, TN, 37027
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Ardent Health Partners, Inc. (2024–2025) · Ardent Health Partners, LLC (2018–2024)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$6.41B
Net Income
$78.23M
Total Assets
$5.28B
Total Equity
$1.75B
Total Debt
$1.10B
Free Cash Flow
-
Ratios
Net Margin
1.2%
Return on Equity
4.5%
Return on Assets
1.5%
Current Ratio
2.1x
Debt / Equity
0.63x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Ardent Health, Inc. generated $6.32B of revenue in fiscal 2025, with net income of $135.81M and an operating cash inflow of $470.51M. At $6.32B, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $5.97B in fiscal 2024, revenue recorded a 6.0% year-over-year increase. Diluted earnings per share were $0.96, translating the period’s attributable earnings into the amount reported for each diluted share. Against diluted EPS of $1.58 in fiscal 2024, the current result was 39.2% lower. The diluted weighted-average share count was 141.45M, linking total earnings with the per-share result received by shareholders. Total assets stood at $5.29B, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 1.2x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

After all reported below-operating-line items, the company recorded net income of $135.81M for the fiscal year. Net margin was 2.1%, meaning that this portion of revenue remained as net income after all recognized expenses. The earnings statement records $286.36M of pretax income, the profit base against which the reported tax provision can be assessed. Measured against revenue, pretax income equaled 4.5%, adding a pre-tax profitability layer between revenue and net income. The company recognized $56.22M of income tax for the period, completing the transition from pretax income to net income. The effective relationship between income tax and positive pretax income was 19.6%, without assuming a statutory-rate comparison. Net income equaled 8.1% of period-end equity, showing the earnings generated on shareholders’ book capital. Net income represented 2.6% of period-end assets, placing the company’s bottom-line result against the total resource base employed. Current net income of $135.81M was below fiscal 2024 net income of $210.34M, showing the direction of the bottom-line change.

Liquidity and Capital Structure

At period end, the $5.29B asset base was financed through $3.61B of liabilities and $1.69B of equity. At period end, current assets of $2.06B compared with current liabilities of $1.05B, defining the company’s short-term resource position. The current ratio was 1.97x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Cash and equivalents totaled $709.60M, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 67.8%, excluding receivables and other current assets. The company carried $1.10B of total debt at period end, which frames its leverage and debt-service burden. The debt-to-equity relationship was 0.65x, showing how much debt the company carried for each unit of book equity. Debt represented 20.8% of total assets, placing borrowing in the context of the company’s full resource base. Book equity represented 31.9% of total assets, quantifying the balance-sheet share supported by shareholder capital. Liabilities represented 68.1% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 13.4%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 6.7% higher than fiscal 2024 assets of $4.96B, measuring the company’s own balance-sheet change. Against $1.52B of equity in fiscal 2024, the current book-equity balance moved 10.8% and ended higher. Cash and equivalents were 27.4% higher than fiscal 2024 cash of $556.78M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was $470.51M, a reported cash inflow that can be compared directly with net income and capital spending. Operating cash flow equaled 3.46x of net income, showing how strongly accounting earnings converted into cash from operations.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Ardent Health, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $6.32B $5.97B $5.41B
OPERATING EXPENSES
SG&A Expense $140.80M $132.40M $114.60M
NON-OPERATING INCOME / EXPENSE
Pretax Income $286.36M $363.06M $151.61M
Income Tax $56.22M $63.35M $22.64M
Net Income $135.81M $210.34M $53.90M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.96 $1.58 $0.43
Diluted Shares 141.45M 132.74M 126.12M
Depreciation & Amortization $155.70M $146.29M $140.84M
Balance Sheet
ASSETS
Cash & Equivalents $709.60M $556.79M $437.58M
Accounts Receivable $686.10M $743.03M $775.45M
Inventory $118.59M $115.09M $105.49M
Other Current Assets $431.88M $304.09M $222.29M
Current Assets $2.06B $1.83B $1.62B
PP&E (Net) $935.77M $861.90M $811.09M
Goodwill $879.45M $852.08M $844.70M
Intangible Assets $12.40M - -
Other Noncurrent Assets $111.69M $142.97M $147.11M
Noncurrent Assets $3.23B $3.12B $3.11B
Total Assets $5.29B $4.96B $4.73B
LIABILITIES
Accounts Payable $457.94M $401.25M $474.54M
Short-term Debt $23.44M $9.23M $18.61M
Other Current Liabilities $268.90M $239.82M $233.27M
Current Liabilities $1.05B $945.42M $994.10M
Long-term Debt $1.08B $1.09B $1.17B
Other Noncurrent Liabilities $76.64M $34.70M $76.00M
Noncurrent Liabilities $2.56B $2.49B $2.66B
Total Liabilities $3.61B $3.43B $3.65B
EQUITY
Common Stock $1.43M $1.43M $0
Additional Paid-in Capital $788.47M $754.42M $0
Retained Earnings $501.61M $365.80M $155.45M
Accumulated OCI $-3.61M $9.74M $18.56M
Total Equity $1.69B $1.52B $1.08B
Temporary Equity $-1.25M $1.16M $7.30M
Total Liabilities & Equity $5.29B $4.96B $4.73B
SUPPLEMENTAL
Total Debt $1.10B $1.10B $1.19B
Shares Outstanding 142.86M 142.75M 0.00
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $470.51M $315.03M $221.70M
Capital Expenditures - - -
Cash from Investing $-214.23M $-220.46M $-137.98M
Cash from Financing $-103.47M $24.64M $-102.26M
Free Cash Flow - - -
Beginning Cash (CFS) $556.79M $437.58M $456.12M
Net Change in Cash $152.82M $119.21M $-18.55M
Effect of FX on Cash - - -
Calculated Ending Cash $709.60M $556.79M $437.58M
Cash per BS $709.60M $556.79M $437.58M
Cash scope difference (CFS − BS) - - -
Cash per CFS $709.60M $556.79M $437.58M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Ardent Health, Inc.'s annual revenue?

Ardent Health, Inc. reported $6.41B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Ardent Health, Inc. profitable?

Yes. Ardent Health, Inc. reported $78.23M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is Ardent Health, Inc.'s debt level?

Ardent Health, Inc. carries $1.10B in total debt as of trailing twelve months. Total shareholders' equity stands at $1.75B.